Aptinyx (APTX) Tops Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. JBLU
2. META
3. SSD
4. AVGO
5. CDNS
6. PECO
7. AGYS
8. HWKN
9. INTC
10. RMBS

Go back to Aptinyx (APTX) Tops Q4 EPS by 4c

Aptinyx Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

March 24, 2021 4:05 PM EDT

Phase 2 studies in fibromyalgia and painful DPN enrolling as planned data readouts expected in 1H 2022

Phase 2 study in cognitive impairment expected to recommence imminently data readout expected in 2H 2022

Reported data from Phase 2 exploratory study of NYX-783 in PTSD, supporting further clinical development meeting with FDA to discuss future development path April 29, 2021

Strong cash position expected to support operations through multiple clinical data readouts and into 2023

Conference call today at 5:00 p.m. EST

EVANSTON, Ill.--(BUSINESS WIRE)-- Aptinyx Inc. (Nasdaq:... More